Regulations under the Health Act 2009: Control of Entry and Exit in the NHS Pharmaceutical Market: Impact Assessment
Impact assessment (IA 5035) on the control of entry and exit in the NHS pharmaceutical market
Documents
Details
To ensure a proportionate regulatory regime which encourages the supply of NHS pharmaceutical services without excessive provision in areas already adequately meeting demand, to ensure the benefits of new entry outweigh costs and to align provision more transparently with local needs.